Ann: Increased Scheme Consideration from Pfizer, page-325

A pretty serious presentation with no hint of any smiles from TK. I gained the impression from body language that he really wished he didn’t need to go through the exercise.

Nonetheless a couple of comments were informative.

“The (Confirmatory) clinical study is essentially a carbon copy of the one we ran before. … Very, very similar data to what we had before, so there is a very high chance of success.”

“We’re talking about Pfizer acquiring the Company, so the Company would then become part of Pfizer and really give us the opportunity to tale this technology to the World.” (i.e. the reduction of uncertainty for the Company takes priority over the interest of shareholders).